multiple sclerosis/kanabis

Povezava se shrani v odložišče

Izberite vrsto razvrščanja

Stran 1 iz 457 rezultatov

Discontinuing cannabis improves depression in people with multiple sclerosis: A short report

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

To assess whether symptoms of depression change when people with multiple sclerosis (pwMS) discontinue cannabis use, 40 cognitively impaired pwMS who smoked cannabis almost daily were randomly assigned to either a cannabis continuation (CC) or cannabis withdrawal (CW) group. Both groups were

Do cannabinoids reduce multiple sclerosis-related spasticity?

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND The plant Cannabis sativa contains numerous cannabinoids, which are aromatic hydrocarbons that have central nervous system effects mediated through specific cannabinoid receptors. Some patients with multiple sclerosis (MS) report symptomatic relief from spasticity, pain, and other

Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Although clinical studies show that cannabinoids improve central pain in patients with multiple sclerosis (MS) neurophysiological studies are lacking to investigate whether they also suppress these patients' electrophysiological responses to noxious stimulation. The flexion reflex (FR) in humans is

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Symptoms relating to spasticity are common in multiple sclerosis (MS) and can be difficult to treat. We have investigated the efficacy, safety and tolerability of a standardized oromucosal whole plant cannabis-based medicine (CBM) containing delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD),

Effects of cannabis on cognitive function in patients with multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND While neuropsychological deficits have been reported in healthy individuals who use street cannabis, data in patients with multiple sclerosis (MS) are lacking. Given that MS is associated with cognitive deterioration, the aim of this study was to determine the neuropsychological effects

The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The aim of this observational study was to assess the efficacy of a tetrahydrocannabinol-cannabidiol (THC : CBD) oromucosal spray on spasticity using the stretch reflex in patients with multiple sclerosis (MS). Numeric rating scale (NRS) for spasticity, modified Ashworth scale (MAS), and the stretch

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The object of this study was to monitor the safety and efficacy of long-term use of an oromucosal cannabis-based medicine (CBM) in patients with multiple sclerosis (MS). A total of 137 MS patients with symptoms not controlled satisfactorily using standard drugs entered this open-label trial

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Increasing evidence supports the idea of a beneficial effect of cannabinoid compounds for the treatment of multiple sclerosis (MS). However, most experimental data come from animal models of MS. We investigated the status of cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase (FAAH)

Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

With the expansion of medical and recreational legalization of cannabis, there is growing interest in cannabis use by people with multiple sclerosis (MS). Research supports that cannabis relieves MS-related pain and spasticity, two common symptoms of MS. However, there is limited

Move to legalise cannabis for multiple sclerosis sufferers.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Six MPs from across the parties have signed an Early Day Motion calling for cannabis to be available on prescription to people with multiple sclerosis.

Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Cognitive dysfunction affects 40-80% of patients with multiple sclerosis. Smoking cannabis may add to these deficits. It is unclear whether coming off cannabis results in cognitive improvement. To address this question, 40 patients with multiple sclerosis who started using cannabis after the onset

Cannabis-based medicines in multiple sclerosis--a review of clinical studies.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

For some years a mixture of anecdotal report and data from animal models have implied a potential role for cannabis-based medicines in ameliorating a variety of symptoms of multiple sclerosis. Only recently however have large randomised controlled trials (RCTs) examined these potential effects

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Cannabis-based medicines have recently been approved for the treatment of pain and spasticity in multiple sclerosis (MS). This supports the original perceptions of people with MS, who were using illegal street cannabis for symptom control and pre-clinical testing in animal models of MS. This

Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

BACKGROUND Maintenance of the blind-to-treatment allocation is one of the most important means of avoiding bias in randomised controlled clinical trials. Commonly used methodologies to determine whether patients have become unblinded to treatment allocation are imperfect. This may be of particular

Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis?

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The effectiveness of cannabinoids (CB) in the treatment of pain in patients with multiple sclerosis (MS) varies. The pathogenesis of pain in MS is diverse as are the possible effects of CB at different sites of CB receptors in the peripheral and central nervous system, this may explain the variable

Prejšnji
1
2
3
4
5
6
...
30
31
Naslednji

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah